In MM patients, MM-associated bone disease (MBD), characterized by osteolytic lesions, is mainly triggered by the high upregulation of DKK1 secreted by malignant plasma cells in the bone marrow microenvironment (Zhou et al., 2013). Here, DKK1 is linked to Miyoshi myopathy.